FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for treating castration-resistant prostate cancer. For this purpose, simultaneously with a combination of docetaxel 75 mg/m2 of body surface once in 3 weeks + abiraterone 1000 mg a day + prednisolone 10 mg a day intravenously dropwise introduction of succinic acid solution in form of methylglucamine mixtures in amount of 5–6 g of succinic acid per 1 litre of infusion mixture. Duration of therapeutic course is 3 weeks.
EFFECT: method enables higher clinical effectiveness and safety ensured by the additive effect of the combination.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CASTRATION-RESISTANT PROSTATE CANCER | 2017 |
|
RU2673816C1 |
| METHOD OF CASTRATION-RESISTANT PROSTATE CANCER TREATMENT | 2017 |
|
RU2696287C2 |
| METHOD OF CASTRATION-RESISTANT PROSTATE CANCER TREATMENT | 2017 |
|
RU2696288C2 |
| METHOD OF CASTRATION-RESISTANT PROSTATE CANCER TREATMENT | 2017 |
|
RU2694259C2 |
| METHOD OF CASTRATION-RESISTANT PROSTATE CANCER TREATMENT | 2017 |
|
RU2694373C2 |
| MEANS OF TREATMENT AND RELAPSE PREVENTION OF PROSTATE CANCER | 2006 |
|
RU2325160C1 |
| ABIRATERONE PRODRUGS | 2020 |
|
RU2822219C2 |
| METHOD FOR TREATING SKIN DISEASES, BURNS, SUPERFICIAL AND DEEP WOUND | 2017 |
|
RU2706722C2 |
| COMBINATION TREATMENT OF CANCER | 2012 |
|
RU2640485C2 |
| CANCER TREATMENT METHODS | 2019 |
|
RU2811406C2 |
